Martin-Oliva et al., Cancer Res 2006
(Cell Transformation, Neoplastic...) :
Inhibition of PARP also affected activator protein-1 (AP-1) activation but not nuclear factor-kappaB (NF-kappaB)
GarcĂa et al., Ann Rheum Dis 2008
(Arthritis, Rheumatoid) :
PARP inhibition reduced TNF induced JNK phosphorylation and AP-1 and NF kappaB binding activities were partially impaired by treatment with PARP inhibitors or by PARP-1 knockdown